Literature DB >> 11583814

A new functional domain of Bcl6 family that recruits histone deacetylases.

H Zhang1, S Okada, M Hatano, S Okabe, T Tokuhisa.   

Abstract

The proto-oncogene Bcl6 and its family gene, BAZF, encode a sequence-specific transcriptional repressor which contains the BTB/POZ domain in NH(2)-terminal region and zinc finger motifs in COOH-terminal region. The BTB/POZ domain and the middle portion of Bcl6 and BAZF are known to display transrepressor activity. Since we have identified the identical 17-amino acid (aa) sequence in the middle portion of Bcl6 and BAZF, the 17aa region may be another repressive domain of the middle portion. The reporter gene assay indicates that the 27aa sequence including the 17aa region recruits histone deacetylases to express transrepressor activity. Furthermore, overexpression of Bcl6 or Bcl6(POZ-) (Bcl6 deleted with the BTB/POZ domain) induced apoptosis in NIH3T3 cells, and the apoptosis was inhibited by the addition of histone deacetylase inhibitor in the culture. However, apoptosis was not induced in NIH3T3 cells by overexpression of Bcl6(POZ-) deleted with the 17aa region. These results indicate that the 17aa region in the middle portion of Bcl6 is a functional domain of transrepressor activity and is responsible for inducibility of apoptosis in NIH3T3 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583814     DOI: 10.1016/s0167-4889(01)00128-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.

Authors:  Sui Hu; Baoping Cao; Meiying Zhang; Enqiang Linghu; Qimin Zhan; Malcolm V Brock; James G Herman; Gaoping Mao; Mingzhou Guo
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

2.  CtBP is an essential corepressor for BCL6 autoregulation.

Authors:  Lourdes M Mendez; Jose M Polo; J Jessica Yu; Melissa Krupski; B Belinda Ding; Ari Melnick; B Hilda Ye
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

3.  BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner.

Authors:  Stella Maris Ranuncolo; Ling Wang; Jose M Polo; Tania Dell'Oso; Jamil Dierov; Terry J Gaymes; Feyruz Rassool; Martin Carroll; Ari Melnick
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

4.  Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design.

Authors:  Huimin Cheng; Brian M Linhares; Wenbo Yu; Mariano G Cardenas; Yong Ai; Wenjuan Jiang; Alyssa Winkler; Sandra Cohen; Ari Melnick; Alexander MacKerell; Tomasz Cierpicki; Fengtian Xue
Journal:  J Med Chem       Date:  2018-07-17       Impact factor: 7.446

5.  PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells.

Authors:  Fang Wei; Kristina Zaprazna; Junwen Wang; Michael L Atchison
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

6.  Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.

Authors:  Yong Ai; Lucia Hwang; Alexander D MacKerell; Ari Melnick; Fengtian Xue
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

7.  Analysis of Combined Transcriptomes Identifies Gene Modules that Differentially Respond to Pathogenic Stimulation of Vascular Smooth Muscle and Endothelial Cells.

Authors:  Xiaokang Pan; Bowen Wang; Tiezheng Yuan; Mengxue Zhang; K Craig Kent; Lian-Wang Guo
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 8.  A short guide to histone deacetylases including recent progress on class II enzymes.

Authors:  Suk-Youl Park; Jeong-Sun Kim
Journal:  Exp Mol Med       Date:  2020-02-19       Impact factor: 8.718

9.  The survival decrease in gastric cancer is associated with the methylation of B-cell CLL/lymphoma 6 member B promoter.

Authors:  Jingyu Deng; Han Liang; Qiuping Dong; Yachao Hou; Xingming Xie; Jun Yu; Daiming Fan; Xishan Hao
Journal:  Open Biol       Date:  2014-07       Impact factor: 6.411

10.  BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.

Authors:  Yue Gu; Aifang Li; Hui Sun; Xueru Li; He Zha; Jiali Zhao; Jiaqing Xie; Zongyue Zeng; Lan Zhou
Journal:  Int J Mol Med       Date:  2018-02-01       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.